Oncology - Leukemia/Lymphoma News & Articles

121 The changing mutational landscape of acute myeloid leukemia and myelodysplastic syndrome Molecular Cancer Research, May 13, 2013    Review Article

122 High level of CD20 expression by flow cytometry predicts good prognosis in chronic lymphocytic leukemia Cancer Science, May 13, 2013    Clinical Article

123 Trends in utilization and survival after autologous hematopoietic cell transplantation in North America from 1995 to 2005: Significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age Biology of Blood and Marrow Transplantation, May 13, 2013    Clinical Article

124 Protein-coding genes and long noncoding RNAs are differentially expressed in dasatinib-treated chronic myeloid leukemia patients with resistance to imatinib Hematology, May 13, 2013    Clinical Article

125 Extended lifespan of normal human B lymphocytes experimentally infected by SV40 or transfected by SV40 large T antigen expression vector Leukemia Research, May 13, 2013    Clinical Article

126 TCTP/HRF pathway and angiogenesis: A feasible intercourse in chronic lymphocytic leukemia Leukemia Research, May 13, 2013    Clinical Article

127 Absolute lymphocyte count is associated with minimal residual disease level in childhood B-cell precursor acute lymphoblastic leukemia Leukemia Research, May 13, 2013    Clinical Article

128 Tumor lysis syndrome soon after treatment with hydroxyurea followed by nilotinib in two patients with chronic-phase chronic myelogenous leukemia International Journal of Hematology, May 13, 2013    Clinical Article

129 Oncogenic CSF3R Mutations in Chronic Neutrophilic Leukemia and Atypical CML New England Journal of Medicine, May 13, 2013    Evidence Based Medicine    Clinical Article

130 Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial The Lancet Oncology, May 10, 2013    Clinical Article

131 Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors British Journal of Cancer, May 10, 2013

132 Somatic hypermutation analysis in follicular lymphoma provides evidence suggesting bidirectional cell migration between lymph node and bone marrow during disease progression and relapse Full Text Haematologica, May 10, 2013    Clinical Article

133 Inactivation of PTEN increases ABCG2 expression and the side population through the PI3K/Akt pathway in adult acute leukemia Cancer Letters, May 10, 2013    Clinical Article

134 Determination of the molecular subtypes of diffuse large B-cell lymphomas using immunohistochemistry: a case series from the Inselspital, Bern, and a critical appraisal of this determination in Switzerland Full Text Swiss Medical Weekly, May 10, 2013

135 Igs Expressed by Chronic Lymphocytic Leukemia B Cells Show Limited Binding-Site Structure Variability The Journal of Immunology, May 10, 2013    Clinical Article

136 Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): A report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM) Leukemia Research, May 10, 2013    Clinical Article

137 Epstein-Barr Virus–Encoded miR-BART20-5p Inhibits T-bet Translation with Secondary Suppression of p53 in Invasive Nasal NK/T-Cell Lymphoma American Journal of Pathology, May 10, 2013    Clinical Article
Exclusive Author Commentary

138 MYC status determination in aggressive B-cell lymphoma: the impact of FISH probe selection Histopathology, May 10, 2013    Clinical Article

139 Multicenter phase II study of bendamustine plus rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma Journal of Clinical Oncology, May 9, 2013    Clinical Article

140 Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia Journal of Clinical Oncology, May 9, 2013

1 R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: Results of the FOLL05 Trial conducted by the Fondazione Italiana Linfomi Journal of Clinical Oncology, April 1, 2013

2 Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013 Mayo Clinic Proceedings, April 2, 2013    Clinical Guideline

3 Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202) Journal of Clinical Oncology, April 15, 2013

4 The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi Annals of Oncology, April 19, 2013

5 The role of maintenance therapy in acute promyelocytic leukemia in the first complete remission Cochrane Reviews, April 3, 2013    Evidence Based Medicine

6 Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial The Lancet Oncology, April 12, 2013
Exclusive Author Commentary

7 Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles The Lancet, April 23, 2013

8 90Yttrium-Ibritumomab Tiuxetan Consolidation of First Remission in Advanced-Stage Follicular Non-Hodgkin Lymphoma: Updated Results After a Median Follow-Up of 7.3 Years From the International, Randomized, Phase III First-Line Indolent Trial Journal of Clinical Oncology, April 4, 2013

9 Expression of CD133 in acute leukemia Medical Oncology, April 2, 2013

10 The changing paradigm of CLL management European Journal of Internal Medicine , April 17, 2013    Review Article

11 Leukaemia update. Part 1: diagnosis and management British Medical Journal, April 9, 2013    Review Article

12 Alcohol consumption and risk of lymphoid and myeloid neoplasms: Results of the Netherlands cohort study International Journal of Cancer, April 4, 2013

13 Curability of patients with acute myeloid leukemia who did not undergo transplantation in first remission Journal of Clinical Oncology, March 4, 2013

14 Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib Leukemia, April 11, 2013

15 Bendamustine compared to fludarabine as second-line treatment in chronic lymphocytic leukemia Annals of Hematology, April 9, 2013

16 Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patients Journal of Hematology & Oncology, April 18, 2013    Free full text

17 Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Childrens Oncology Group phase 1 consortium study The Lancet Oncology, April 24, 2013

18 Prospective phase ii study on 5-days azacitidine (5d-aza) for treatment of symptomatic and/or erythropoietin unresponsive patients with low/int-1 risk myelodysplastic syndromes. Clinical Cancer Research, April 19, 2013

19 An antiapoptotic Bcl-2 family protein index predicts the response of leukaemic cells to the pan-Bcl-2 inhibitor S1 British Journal of Cancer, April 10, 2013

20 Salvage therapy using FLT3 inhibitors may improve long-term outcome of relapsed or refractory AML in patients with FLT3-ITD British Journal of Haematology, April 1, 2013